Cargando…
Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis
Fibroblast growth factor 21 (FGF21) is an atypical member of the FGF family. Acting in an endocrine fashion, it increases glucose uptake, modulates lipid metabolism, and sensitizes insulin response in metabolically active organs, including the liver and adipose tissue. Emerging evidence shows a stro...
Autores principales: | Kwok, Kelvin H. M., Lam, Karen S. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Endocrine Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503858/ https://www.ncbi.nlm.nih.gov/pubmed/28537053 http://dx.doi.org/10.3803/EnM.2017.32.2.145 |
Ejemplares similares
-
The relationship of circulating fibroblast growth factor 21 levels with pericardial fat: The Multi-Ethnic Study of Atherosclerosis
por: Magdas, Arsenios, et al.
Publicado: (2019) -
Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk
por: Jin, Leigang, et al.
Publicado: (2016) -
Fibroblast growth factor 21 in heart failure
por: Tucker, William, et al.
Publicado: (2022) -
Sex Modifies the Association of Fibroblast Growth Factor 21 With Subclinical Carotid Atherosclerosis
por: Chee, Yingjie, et al.
Publicado: (2021) -
Fibroblast Growth Factor 21 Facilitates the Homeostatic Control of Feeding Behavior
por: Wu, Chih-Ting, et al.
Publicado: (2022)